Product Category
Contact Us
Address: No.80, Spring Equinox Road, Huangpu District, Guangzhou
Telephone:86020-8328 9091
Adverse Drug Reaction/Event Feedback E-mail:pvreport@bio-current.com
Linked API
Indications | Drug Name | Review Status | Registration Number |
Multiple Myeloma | Lenalidomide | A | Y20220000832 |
Pomalidomide | Upcoming filing | ||
Chronic Myeloid Leukemia | Imatinib | I | Y20230000285 |
Dasatinib | Upcoming filing | ||
Nilotinib | Upcoming filing | ||
Non-Small Cell Lung Lancer | Erlotinib | I | Y20220001100 |
Osimertinib | Prepare for filing | ||
Crizotinib | Upcoming filing | ||
Ceritinib | Prepare for filing | ||
Alectinib | Prepare for filing | ||
Renal Cell Carcinoma, Gastrointestinal Stromal Tumor | Sunitinib | I | Y20230000858 |
Renal Cell Carcinoma | Axitinib | I | Y20240000536 |
Liver Cancer | Sorafenib | Prepare for filing | |
Lenvatinib | Upcoming filing | ||
Breast Cancer | Lapatinib | Upcoming filing | |
Palbociclib | Upcoming filing | ||
Olaparib | Prepare for filing | ||
Lymphoma | Ibrutinib | Upcoming filing | |
Melanoma | Trametinib | Upcoming filing | |
Dabrafenib | Prepare for filing | ||
Myelofibrosis | Ruxolitinib | Prepare for filing | |
Prostate Cancer | Enzalutamide | Prepare for filing |